Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring a (BPD-MA)-PDT in vitro and correlation with MLL cell survival

Photochemistry and Photobiology

Volumn 87, Issue 5, 2011, Pages 1129-1137

  Weston, Mark A ^a   Patterson, Michael S ^b  

^a JURAVINSKI CANCER CENTRE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; PHOTOSENSITIZING AGENT; PORPHYRIN; SINGLET OXYGEN; VERTEPORFIN;

ADENOCARCINOMA; ANIMAL; ANOXIA; ARTICLE; BLEACHING; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; FLUORESCENCE; HUMAN; KINETICS; MALE; METABOLISM; METHODOLOGY; OXYGEN CONSUMPTION; PATHOLOGY; PHOTOCHEMOTHERAPY; PROSTATE TUMOR; RADIATION DOSE; RADIATION EXPOSURE; RAT; SPECTROFLUOROMETRY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANOXIA; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENCE; HUMANS; KINETICS; LIPOSOMES; MALE; OXYGEN CONSUMPTION; PHOTOBLEACHING; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RATS; SINGLET OXYGEN; SPECTROMETRY, FLUORESCENCE;

EID: 80052397484     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2011.00942.x     Document Type: Article

References (32)

1. Augustin, A. J., S. Scholl, and, J. Kirchhof, (2009) Treatment of neovascular age-related macular degeneration: Current therapies. Clin. Ophthalmol. 3, 175-182.
2. Nestor, M. S., M. H. Gold, A. N. Kauvar, A. F. Taub, R. G. Geronemus, E. C. Ritvo, M. P. Goldman, D. J. Gilbert, D. F. Richey, T. S. Alster, R. R. Anderson, D. E. Bank, A. Carruthers, J. Carruthers, D. J. Goldberg, C. W. Hanke, N. J. Lowe, D. M. Pariser, D. S. Rigel, P. Robins, J. M. Spencer, and, B. D. Zelickson, (2006) The use of photodynamic therapy in dermatology: Results of a consensus conference. J. Drugs Dermatol. 5, 140-154.
3. Nseyo, U. O., J. DeHaven, T. J. Dougherty, W. R. Potter, D. L. Merrill, S. L. Lundahl, and, D. L. Lamm, (1998) Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: A long-term experience. J. Clin. Laser Med. Surg. 16, 61-68.
4. Wilson, B. C., and, M. S. Patterson, (2008) The physics, biophysics and technology of photodynamic therapy. Phys. Med. Biol. 53, R61-R109.
5. Foote, C., (1991) Definition of type I and type II photosensitized oxidation. Photochem. Photobiol. 54, 659.
6. Laubach, H. J., S. K. Chang, S. Lee, I. Rizvi, D. Zurakowski, S. J. Davis, C. R. Taylor, and, T. Hasan, (2008) In-vivo singlet oxygen dosimetry of clinical 5-aminolevulinic acid photodynamic therapy. J. Biomed. Opt. 13, 050504.
7. Niedre, M. J., A. J. Secord, M. S. Patterson, and, B. C. Wilson, (2003) In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy. Cancer Res. 63, 7986-7994.
8. Niedre, M. J., M. S. Patterson, A. Giles, and, B. C. Wilson, (2005) Imaging of photodynamically generated singlet oxygen luminescence in vivo. Photochem. Photobiol. 81, 941-943.
9. Wilson, B. C., M. S. Patterson, and, L. Lilge, (1997) Implicit and explicit dosimetry in photodynamic therapy: A new paradigm. Lasers Med. Sci. 12, 182-199.
10. Jarvi, M. T., M. J. Niedre, M. S. Patterson, and, B. C. Wilson, (2006) Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: Current status, challenges and future prospects. Photochem. Photobiol. 82, 1198-1210.
11. Zhu, T. C., J. C. Finlay, and, S. M. Hahn, (2005) Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. J. Photochem. Photobiol. B 79, 231-241.
12. Betz, C. S., W. Rauschning, E. P. Stranadko, M. V. Riabov, V. Albrecht, N. E. Nifantiev, and, C. Hopper, (2008) Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas. Lasers Surg. Med. 40, 300-311.
13. Dysart, J. S., G. Singh, and, M. S. Patterson, (2005) Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells. Photochem. Photobiol. 81, 196-205.
14. Dysart, J. S., and, M. S. Patterson, (2005) Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro. Phys. Med. Biol. 50, 2597-2616.
15. Dysart, J. S., and, M. S. Patterson, (2006) Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions. Photochem. Photobiol. Sci. 5, 73-81.
16. Weston, M. A., and, M. S. Patterson, (2009) Simple photodynamic therapy dose models fail to predict the survival of MLL cells after HPPH-PDT in vitro. Photochem. Photobiol. 85, 750-759.
17. Zeng, H., M. Korbelik, D. I. McLean, C. MacAulay, and, H. Lui, (2002) Monitoring photoproduct formation and photobleaching by fluorescence spectroscopy has the potential to improve PDT dosimetry with a verteporfin-like photosensitizer. Photochem. Photobiol. 75, 398-405.
18. Cruess, A. F., G. Zlateva, A. M. Pleil, and, B. Wirostko, (2008) Photodynamic therapy with verteporfin in age-related macular degeneration: A systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties. Acta Ophthalmol. 87, 118-132.
19. Lui, H., L. Hobbs, W. D. Tope, P. K. Lee, C. Elmets, N. Provost, A. Chan, H. Neyndorff, X. Y. Su, H. Jain, I. Hamzavi, D. McLean, and, R. Bissonnette, (2004) Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: Two-year results evaluating tumor response and cosmetic outcomes. Arch. Dermatol. 140, 26-32.
20. Gillies, R., N. Kollias, T. Hasan, and, H. Diddens, (1996) Spectral characterization of the benzoporphyrin derivative monoacid ring-A photoproduct formed in fetal calf solutions during irradiation with 694 nm continuous-wave radiation. J. Photochem. Photobiol. B 33, 87-90.
21. Finlay, J. C., S. Mitra, M. S. Patterson, and, T. H. Foster, (2004) Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms. Phys. Med. Biol. 49, 4837-4860.
22. Dysart, J. S., M. S. Patterson, T. J. Farrell, and, G. Singh, (2002) Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells. Photochem. Photobiol. 75, 289-295.
23. Georgakoudi, I., M. G. Nichols, and, T. H. Foster, (1997) The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry. Photochem. Photobiol. 65, 135-144.
24. Kawauchi, S., S. Sato, Y. Morimoto, and, M. Kikuchi, (2004) Correlation between oxygen consumption and photobleaching during in vitro photodynamic treatment with ATX-S10.Na(II) using pulsed light excitation: Dependence of pulse repetition rate and irradiation time. Photochem. Photobiol. 80, 216-223.
25. Jin, C., Z. Wu, Y. Li, Y. Li, H. Chen, and, J. North, (1999) The killing effect of photodynamic therapy using benzoporphyrin derivative on retinoblastoma cell line in vitro. Yan. Ke. Xue. Bao. 15, 1-6.
26. Stephan, H., R. Boeloeni, A. Eggert, N. Bornfeld, and, A. Schueler, (2008) Photodynamic therapy in retinoblastoma: Effects of verteporfin on retinoblastoma cell lines. Invest. Ophthalmol. Vis. Sci. 49, 3158-3163.
27. Rousset, N., V. Vonarx, S. Eleouet, J. Carre, L. Bourre, Y. Lajat, and, T. Patrice, (2000) Cellular distribution and phototoxicity of benzoporphyrin derivative and Photofrin. Res. Exp. Med. (Berl) 199, 341-357.
28. Akens, M. K., A. J. Yee, B. C. Wilson, S. Burch, C. L. Johnson, L. Lilge, and, S. K. Bisland, (2007) Photodynamic therapy of vertebral metastases: Evaluating tumor-to-neural tissue uptake of BPD-MA and ALA-PpIX in a murine model of metastatic human breast carcinoma. Photochem. Photobiol. 83, 1034-1039.
29. Aveline, B., T. Hasan, and, R. W. Redmond, (1994) Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA). Photochem. Photobiol. 59, 328-335.
30. Mitra, S., and, T. H. Foster, (2000) Photochemical oxygen consumption sensitized by a porphyrin phosphorescent probe in two model systems. Biophys. J. 78, 2597-2605.
31. Mitra, S., and, T. H. Foster, (2005) Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin. Photochem. Photobiol. 81, 849-859.
32. Samkoe, K. S., M. S. Fecica, R. L. Goyan, J. L. Buchholz, C. Campbell, N. M. Kelly, and, D. T. Cramb, (2006) Photobleaching kinetics of optically trapped multilamellar vesicles containing verteporfin using two-photon excitation section sign. Photochem. Photobiol. 82, 152-157.